- About us
- Join Putnam
We provide commercial consulting and advisory solutions across the product development and commercialization lifecycle.
Grounded in scientific and strategic excellence and delivered by experts with deep therapeutic area expertise, our solutions help maximize the commercial success of your product and portfolio to ensure the greatest clinical impact to patients.
Our pharmaceutical commercialization services span the product lifecycle, serving many of the most innovative and fastest-growing products of the last decade.
With our comprehensive understanding of the clinical landscape, commercial landscape, and interdisciplinary approach, we help our clients make decisions that maximize their product’s impact.
At each phase of the product journey, our strategies will help you commercialize with confidence.
See how we’re helping clients solve key challenges and deliver on their ambitions.
Our client, the VP of a core product franchise at a top biopharma company needed to identify key opportunities for their business and capture a...
The client team wanted to create a best-in-class data platform to support insights, forecasting, targeting, next generation data modeling....
We worked with our client to develop a forward-looking early development program evaluation tool that identifies key inflection points...
Chief Operating Officer, Commercial Practice Lead
Matt serves clients within the life science industry on commercial strategy issues. He has led projects that leverage detailed and integrative analytics to inform critical strategic decisions, focused on market opportunity identification (including physician and patient segmentation), product positioning and launch strategies, and customer engagement model design. He has deep expertise in complex hematology/ oncology, immunology, and orphan disease markets, with significant experience in cardiovascular, CNS, and infectious disease markets. He has led multiple internal knowledge development initiatives for the firm, including research on state-of-the art approaches to segmentation, understanding adherence from a business perspective, and integrating clinical and access research to inform comprehensive assessments of market potential.
Get the latest insights and perspectives from our experts.
Supporting and empowering patients are objectives stated by nearly every life science company. Yet efforts to support patient engagement often...
An emerging biotech sought Putnam’s guidance to design and execute the global commercialization of their asset for a rare oncology indication.
A rapidly shifting healthcare landscape and a wave of cost-containment initiatives destined to put further pressure on the pricing of pharmaceuticals